BIOMARKER FOR DIAGNOSIS OR CONFIRMING OF PROGRESS STAGE OF GLIOBLASTOMA AND THE USE THEREOF

摘要

PURPOSE: A biomarker for diagnosing glioblastoma is provided to predict glioblastoma patient's prognosis and to develop anticancer drugs. CONSTITUTION: A biomarker for diagnosing or predicting glioblastoma includes survivin, cyclinE, DCC, TGF-β, CDC25B, Histone H1, p-EGFR, p-VEGFR2/3, or p16. A kit for diagnosing or predicting glioblastoma contains a material for measuring expression level of a gene encoding survivin, cyclinE, DCC, TGF-β, CDC25B, Histone H1, p-EGFR, p-VEGFR2/3 or p16 protein. The material is a primer with a sequence specific to the gene.